Tg Therapeutics (TGTX) Capital Expenditures (QoQ) (2013 - 2026)
Tg Therapeutics (TGTX) Capital Expenditures (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.88% |
| Dec 31, 2025 | -16.25% |
| Sep 30, 2025 | 90.48% |
| Jun 30, 2025 | 68.00% |
| Mar 31, 2025 | 19.05% |
| Dec 31, 2024 | -12.50% |
| Dec 31, 2022 | -25.00% |
| Mar 31, 2022 | -91.25% |
| Dec 31, 2021 | 1.27% |
| Sep 30, 2021 | -54.86% |
| Jun 30, 2021 | 161.19% |
| Mar 31, 2021 | -56.77% |
| Dec 31, 2020 | 74.16% |
| Sep 30, 2020 | 97.78% |
| Jun 30, 2020 | -33.82% |
| Mar 31, 2020 | 100.00% |
| Dec 31, 2019 | -47.69% |
| Sep 30, 2019 | 261.11% |
| Jun 30, 2019 | 28.57% |
| Mar 31, 2019 | 133.33% |